Devices/Safety Alert·FDA MedWatch Safety Alerts

Anesthesia Delivery Systems Recall: GE HealthCare Issues Correction for Certain Carestations due to Risk of Ineffective Ventilation When Used in Volume Control Ventilation (VCV) Mode

HighPublished Jun 5, 2026· AI-analyzed Jun 5, 2026View original FDA source
AI-generated regulatory interpretation. The four sections below are an analyst-style summary produced by an AI model from the original FDA source. Always verify against the source before any regulatory, clinical, or commercial decision.
What happened

GE HealthCare issued a correction for specific Carestation anesthesia delivery systems due to a risk of ineffective ventilation while operating in Volume Control Ventilation (VCV) mode. The manufacturer indicates the issue is signaled by alarms and that other ventilation modes remain functional.

Who it affects

This correction affects GE HealthCare, healthcare facilities utilizing Carestation anesthesia systems, clinical anesthesia providers, and biomedical engineering departments responsible for device maintenance.

Why it matters

The failure of a primary ventilation mode during anesthesia presents a significant clinical risk, though the presence of alarms and the availability of alternative modes may mitigate immediate danger. From a regulatory perspective, this correction suggests a technical software or mechanical failure within the VCV algorithm or delivery mechanism that requires a field correction to ensure device performance meets specifications.

Practical takeaway

Identify and tag affected Carestation units; ensure clinical staff are trained to recognize the specific alarms associated with VCV mode failure and can transition patients to alternative ventilation modes if necessary. Monitor for further manufacturer software or hardware correction instructions.

FDA source material

GE HealthCare is correcting Carestations that may not ventilate properly in VCV mode. The issue is clearly indicated by alarms; other modes remain effective.

Open in openFDA / FDA.gov
AI-generated interpretation. Always verify critical decisions against the original FDA source. Generated with google/gemini-3-flash-preview.